<DOC>
	<DOCNO>NCT01167868</DOCNO>
	<brief_summary>This single multiple ascend dose study healthy male female ( non-child bearing potential ) Japanese White volunteer , assess safety , tolerability , blood urine drug level FosD . FosD develop treatment rheumatoid arthritis .</brief_summary>
	<brief_title>A Study Assess Safety , Tolerability , Blood Urine Drug Levels Fostamatinib Disodium ( FosD ) Healthy Japanese White Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male female ( nonchildbearing potential ) Japanese subject White subject ( origin Europe , Middle East , North Africa ) Body mass index ( BMI ) 17 27 kg/m2 weigh least 45 kg 100 kg History presence respiratory , GI , renal , hepatic , hematological , lymphatic , neurological , cardiovascular , psychiatric , musculoskeletal , genitourinary , immunological , dermatological , connective tissue diseases disorder Any clinically significant illness , acute infection , know inflammatory process , medical/surgical procedure trauma within 4 week first administration investigational product Smoking excess 5 cigarette per day equivalent within 30 day Day 1 Use prescription overthecounter drug within 2 week first administration investigational product</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>fostamatinib disodium</keyword>
	<keyword>FosD</keyword>
	<keyword>Japanese</keyword>
	<keyword>Healthy volunteer</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Single Multiple Ascending Dose Study</keyword>
	<keyword>Healthy Japanese volunteer</keyword>
	<keyword>Healthy White volunteer</keyword>
</DOC>